Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Sep 3, 2019 (7 years ago)

10% Acetyl-L-Cysteine Ophthalmic Solutions

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Processing Controls:

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

10% Acetyl-L-Cysteine Ophthalmic Solutions, dispensed in a) 5ml, b) 10ml c) 15 ml, dropper bottles

Drug: Cysteine Category: Eye Drops & Ophthalmic

Recalling firm
Compounded Solutions in Pharmacy
Origin
CT, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1854-2019 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Cysteine recalls

See all
Class II · Moderate risk

N-A-C

Mislabeling of SUS (N-A-C Sustain 600 mg 100 tab) with N-A-C N-Acetyl-L-Cysteine 500 mg, 100 cap.

Terminated Labeling / mix-up Jarrow Formulas Inc D-0302-2021

Other recalls by Compounded Solutions in Pharmacy

All 2019 recalls